CIK: 1190642 - Address: C/O Lifecore Biomedical, Inc., 3515 Lyman Blvd., Chaska, MN 55318
34 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1116012414308
S%wins69444438252541

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/2/24 18:35
2/1/24
LFCRLifecore Biomedical, Inc. DeDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LMNDM.d00.000102450D
6/9/23 19:53
6/9/23
FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCADS.d-13617.190-8-1934D
6/1/23 19:02
5/31/23
LFCRLifecore Biomedical, Inc. DeDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LMNDM.d00.00097622D
2/21/14 16:59
2/19/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d1,56240.16333920D26516563352418171524-4-5235
2/21/14 16:59
2/19/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-4,916126.3933-39-6620D26516563352418171524-4-5235
2/11/14 20:37
2/7/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d6,80264.473310621D227116412214213-15116647
2/11/14 20:37
2/7/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-12,421117.7433-106-8421D227116412214213-15116647
8/8/13 17:01
8/6/13
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d3,31647.92336921D11471562610910032163651
8/8/13 17:01
8/6/13
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-6,30991.1733-69-7721D11471562610910032163651
5/10/13 20:54
5/8/13
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.dm4,85657.81338421D7043222316810145143472
5/10/13 20:54
5/8/13
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.dm-8,694103.4933-84-8021D7043222316810145143472
11/21/12 15:34
11/20/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d3,35955.98336021D6931218-3-103026-25092
11/21/12 15:34
11/20/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-5,36690.9533-59-7421D6931218-3-103026-25092
5/7/12 20:13
5/4/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d3,85638.563310020D7418112713106-1-1-3-761644
5/7/12 20:13
5/4/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-9,25193.0133-99-8320D7418112713106-1-1-3-761644
5/11/11 11:57
5/9/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d1,40241.24333419D11045221413811012-1415
5/11/11 11:57
5/9/11
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-2,54381.1033-31-6319D11045221413811012-1415
11/10/10 18:31
11/8/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d1,26530.13334216D1094420262210113-1-4-582229
11/10/10 18:31
11/8/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-2,70369.6533-39-7116D1094420262210113-1-4-582229
7/16/10 20:35
7/15/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d1,41232.39334412D543173-336322-382160
7/16/10 20:35
7/15/10
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-2,82064.6833-44-7812D543173-336322-382160
11/9/09 12:36
11/6/09
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d1,30740.09333313D2344193-4-44022782245
11/9/09 12:36
11/6/09
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-1,93259.2733-33-7213D2344193-4-44022782245
2/19/09 17:22
2/18/09
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S-10541.8633-3-1713B00-751731
11/13/07 12:42
11/8/07
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d81926.13263118D-1316-8-10-11-5-4-10-40-60-16
11/13/07 12:42
11/8/07
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-2,00964.0926-31-6418D-1316-8-10-11-5-4-10-40-60-16
11/22/06 14:22
11/20/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d2,02276.2424278D-14-25-1-1-4-51-1034142412
11/22/06 14:22
11/20/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-3,182120.0024-27-778D-14-25-1-1-4-51-1034142412
4/5/06 20:05
4/3/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d39888.553051278B-2-60-19-9-8
4/5/06 20:05
4/3/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-491109.0030-5-368B-2-60-19-9-8
3/31/06 20:10
3/29/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,M.d45543.3830118B1-11-18-10-8
3/31/06 20:10
3/29/06
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOEVP,Fin,S.d-1,145109.0030-11-578B1-11-18-10-8
10/29/03 18:17
10/27/03
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOCVP,CorpM.d21613.0128174D-214936-1-12-4-3-2002322-4-26
10/29/03 18:17
10/27/03
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsEdwards Jeffrey LCAOCVP,CorpS.d-1,26776.2728-17-794D-214936-1-12-4-3-2002322-4-26

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact